FIELD: medicine, haematology.
SUBSTANCE: patient with metabolic syndrome is prescribed with individual low-calorie diet calculated in kcal by formula: for women aged 18-30 years old - (0.0621 × body weight, kg + 2.0357) × 240; aged 31-60 years old - (0.0342 × body weight, kg + 3.5377) × 240; over 60 years old (0.0377 × body weight, kg + 2.7545) × 240; for men aged 18-30 years old - (0.0630 × body weight, kg + 2.8957) × 240; aged 31-60 years old - (0.0484 × body weight, kg + 3.6534) × 240; over 60 years old (0.0491 × body weight, kg + 2.4587) × 240. Diet effect is combined with introduction of Zofenopril dosed 60 mg in the morning. Therapy length is 6 months.
EFFECT: method provides potentiated complex effect of diet and specified medicine with fitted therapy length; normalisation of platelet haemostasis and lowered risk of platelet complications.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OPTIMIZATION OF FUNCTIONAL ACTIVITY OF THROMBOCYTES AT METABOLIC SYNDROME | 2007 |
|
RU2343912C1 |
METHOD FOR NORMALIZING THROMBOCYTIC DISORDERS IN CASE OF METABOLIC SYNDROME | 2004 |
|
RU2268046C1 |
METHOD OF DECREASE OF BLOOD PLATES ACTIVITY AT METHABOLIC SYNDROME | 2007 |
|
RU2337683C1 |
METHOD FOR CORRECTING THROMBOCYTIC DYSFUNCTIONS IN CASE OF METABOLIC SYNDROME | 2004 |
|
RU2268041C1 |
METHOD OF THROMBOCYTE DISTURBANCE LEVELLING IN METABOLIC SYNDROME | 2007 |
|
RU2329040C1 |
METHOD OF PLATELET DYSFUNCTION LEVELLING ASSOCIATED WITH METABOLIC SYNDROME | 2007 |
|
RU2337678C1 |
METHOD OF TROMBOCYTOPATHY TREATMENT AT METABOLIC SYNDROME | 2007 |
|
RU2338517C1 |
METHOD FOR THROMBOCYTE DISORDERS CORRECTION IN METABOLIC SYNDROME | 2007 |
|
RU2342136C2 |
TREATMENT METHOD FOR PRIMARY HEMOSTASIA DISORDERS IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2342137C2 |
TREATMENT METHOD FOR PLATELET DYSFUNCTION IN METABOLIC SYNDROME PATIENTS | 2007 |
|
RU2342134C1 |
Authors
Dates
2008-11-10—Published
2007-04-05—Filed